United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News FDA grants accelerated approval for Bristol Myers Squibb’s Augtyro for NTRK-positive tumors Bristol Myers Squibb (NYSE: BMY) has received accelerated FDA approval for Augtyro (repotrectinib), a treatment designed for patients… byPallavi MadhirajuJune 14, 2024